Navigation Links
Sinovac Announces Supply Agreement with Boryung Pharmaceutical Company Limited in South Korea
Date:9/2/2009

s that meet EU criterion after a single shot. No severe adverse effects were reported after inoculation. Based on the results of the evaluation, the experts unanimously agreed that Sinovac's H1N1 vaccine is suitable for all people from three to 60 years old and the vaccination schedule is a single shot. The result of the experts' evaluation conference will be submitted to SFDA on September 1st, which will be the primary basis for the SFDA to issue the production license.

About Sinovac

Sinovac Biotech Ltd. is a China-based biopharmaceutical company that focuses on the research, development, manufacture and commercialization of vaccines that protect against human infectious diseases. Sinovac's vaccine products include Healive(R) (hepatitis A), Bilive(R) (combined hepatitis A and B), and Anflu(R) (influenza). Panflu(TM), Sinovac's pandemic influenza vaccine (H5N1), has already been approved for government stockpiling. Sinovac is developing vaccines for enterovirus 71, universal pandemic influenza, Japanese encephalitis, and human rabies. Its wholly owned subsidiary, Tangshan Yian, is conducting field trials for independently developed inactivated animal rabies vaccines.

Safe Harbor Statement

This announcement contains forward-looking statements. These statements are made under the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by words or phrases such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates" and similar statements. Among other things, the business outlook and quotations from management in this press release contain forward-looking statements. Statements that are not historical facts, including statements about Sinovac's beliefs and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. A n
'/>"/>

SOURCE Sinovac Biotech Ltd.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Sinovac to Present at the Brean Murray, Carret & Co. Fourth Investor Tour of China
2. Sinovac Provides Support to Chinas Ministry of Health to Aid Earthquake Victims
3. Sinovac Announces that Government Investigation Rules Out Healives Role in Childs Death
4. Sinovac Reports Unaudited First Quarter 2009 Financial Results
5. Sinovac Schedules 2008 Annual General Meeting
6. Sinovac Reports Unaudited Second Quarter 2009 Financial Results
7. Sinovac Wins Beijing Public Health Bureaus Bid to Supply Seasonal Flu Vaccine Anflu(R) to Beijing Citizens
8. Sinovacs H1N1 Vaccine Passes Experts Evaluation Organized by SFDA
9. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
10. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
11. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2015)... (PRWEB) June 03, 2015 The National ... announce that Maria C. Savoia, M.D., Dean of Medical Education ... Medicine, will become Chair on July 1. , ... of the National Resident Matching Program,” said Dr. Savoia. ... process for matching medical students with training programs, and I ...
(Date:6/3/2015)... 2015 Dr. Steven Reisman, a nationally recognized ... ( http://www.newyorkcardiac.com ) located in NYC, announced today the expansion ... practice. In most cases, depending on the level of care ... call, they will be seen by a cardiologist that same ... cardiologist is to ensure that people who have an urgent ...
(Date:6/3/2015)... Washington, DC (PRWEB) June 03, 2015 ... Inc. will be honored with a Global Inspire Award ... program recognizes the organization’s outstanding volunteers for their leadership, ... global scale. , The recipients of the ... or group of authors whose article has made a ...
(Date:6/3/2015)... panel of independent experts has spent weeks considering the ... awards presented tonight at TU-Automotive Detroit 2015. , Naturally, ... can now be revealed as: , Car Maker of ... aside by taking the coveted Car Maker of the ... of expert judges., Stand out comments included: , ...
(Date:6/3/2015)... 03, 2015 On Sunday, June 7, ... will gather in their local communities to observe the ... across the U.S. and abroad will hold celebrations on ... to the ongoing challenges of cancer survivorship, and to ... can be fruitful, rewarding, and inspiring.,  , National Cancer ...
Breaking Medicine News(10 mins):Health News:NRMP Board of Directors Elects New Leadership and Members at its May 2015 Meeting 2Health News:NRMP Board of Directors Elects New Leadership and Members at its May 2015 Meeting 3Health News:NRMP Board of Directors Elects New Leadership and Members at its May 2015 Meeting 4Health News:NYC Cardiologist, Dr. Steven Reisman, Announces Same Day and Evening Appointments 2Health News:Authors Representing TransCelerate BioPharma Inc. to Be Honored with Global Inspire Award at DIA’s 2015 51st Annual Meeting 2Health News:Authors Representing TransCelerate BioPharma Inc. to Be Honored with Global Inspire Award at DIA’s 2015 51st Annual Meeting 3Health News:Authors Representing TransCelerate BioPharma Inc. to Be Honored with Global Inspire Award at DIA’s 2015 51st Annual Meeting 4Health News:TU-Automotive Awards 2015 winners revealed 2Health News:TU-Automotive Awards 2015 winners revealed 3Health News:Communities to Recognize Cancer Survivors, Raise Awareness on National Cancer Survivors Day® – Sunday, June 7 2Health News:Communities to Recognize Cancer Survivors, Raise Awareness on National Cancer Survivors Day® – Sunday, June 7 3Health News:Communities to Recognize Cancer Survivors, Raise Awareness on National Cancer Survivors Day® – Sunday, June 7 4
... or lower clot risk , THURSDAY, Aug. 13 (HealthDay ... influences her risk of developing blood clots of the ... long known that oral contraceptives, which contain the female ... vein thrombosis of the leg and pulmonary embolism, ...
... , , , ... confusion regarding changes to Mississippi Medicaid benefits for speech therapy services, ... the Mississippi Division of Medicaid on the new Medicaid claiming policy ... benefits for speech therapy services provided by school providers, which are ...
... SANTA FE, N.M., Aug. 13 The New Mexico ... new alliance to assist school districts with Medicaid claiming. This program ... will be administered by Accelify. , , "We ... Executive Director. "NMSBA is focused on bringing value-added programs to New ...
... , , BRISTOL, Tenn., ... ) today announced that the U.S. Food and Drug Administration ... Release Capsules for oral use, a long-acting Schedule II opioid ... a continuous, around-the-clock opioid analgesic is needed for an extended ...
... , , ... 2009, Cetyl Max/Flexadren mischaracterized certain facts associated with ... Bulletin Board: IAGX). Both companies extend their apologies ... been affected by the mischaracterization. , ...
... , , , ... SCI ), which owns and operates funeral service locations and cemeteries, ... cash dividend of four cents per share of common stock. ... 2009 to shareholders of record at the close of business on ...
Cached Medicine News:Health News:Some Birth Control Pills Safer Than Others 2Health News:Some Birth Control Pills Safer Than Others 3Health News:Mississippi School Boards Association and Accelify Attain Clarity on New Medicaid Claiming Policy for Coming School Year 2Health News:Mississippi School Boards Association and Accelify Attain Clarity on New Medicaid Claiming Policy for Coming School Year 3Health News:New Mexico School Boards Association and Accelify Announce Alliance to Assist New Mexico Schools 2Health News:Video: FDA Approves EMBEDA(TM) For Management of Moderate to Severe Chronic Pain 2Health News:Video: FDA Approves EMBEDA(TM) For Management of Moderate to Severe Chronic Pain 3Health News:Video: FDA Approves EMBEDA(TM) For Management of Moderate to Severe Chronic Pain 4Health News:Video: FDA Approves EMBEDA(TM) For Management of Moderate to Severe Chronic Pain 5Health News:Video: FDA Approves EMBEDA(TM) For Management of Moderate to Severe Chronic Pain 6Health News:Video: FDA Approves EMBEDA(TM) For Management of Moderate to Severe Chronic Pain 7Health News:Service Corporation International Declares Quarterly Cash Dividend 2Health News:Service Corporation International Declares Quarterly Cash Dividend 3
(Date:6/3/2015)... 3, 2015   Intarcia Therapeutics, Inc. today ... Scientific Sessions of the American Diabetes Association taking ... at the Boston Convention and Exhibition Center. The ... effects of currently marketed and investigational therapies on patients ... of Intarcia,s late-stage clinical candidate, ITCA 650. ...
(Date:6/3/2015)...   Health Data Consortium (HDC) , a public-private partnership whose mission ... to improve health and healthcare, today announced Niall Brennan ... Office of Enterprise Data and Analytics at the Centers ... of this year,s Health Data Liberators Award ... ways to help improve the quality and value of ...
(Date:6/3/2015)... , June 3, 2015 AVT, Inc. (OTC ... automated retailing systems, announced today that their customer, Pharmabox, ... The unique self-service kiosk carries over 140 top selling ... Target, CVS, Walgreen,s or Rite Aid-type store. ... Journal , Miami -based Pharmabox worked ...
Breaking Medicine Technology:Intarcia To Announce Key ITCA 650 Phase 3 Findings And Other Data Presentations At Upcoming 75th Scientific Sessions of the American Diabetes Association In Boston 2Intarcia To Announce Key ITCA 650 Phase 3 Findings And Other Data Presentations At Upcoming 75th Scientific Sessions of the American Diabetes Association In Boston 3Intarcia To Announce Key ITCA 650 Phase 3 Findings And Other Data Presentations At Upcoming 75th Scientific Sessions of the American Diabetes Association In Boston 4CMS Chief Data Officer and Health Data Advocate Niall Brennan Receives Third Annual Health Data Liberators Award 2CMS Chief Data Officer and Health Data Advocate Niall Brennan Receives Third Annual Health Data Liberators Award 3CMS Chief Data Officer and Health Data Advocate Niall Brennan Receives Third Annual Health Data Liberators Award 4Pharmabox Introduces New Concept with a Boldly Designed Automated Retailing System 2
... Pharmaceuticals today issued a voluntary, nationwide, retail-level recall of ... implemented because of a packaging error, where select blisters ... weekly tablet orientation and making the lot number and ... the potential for this error to have affected other ...
... ClinStar, LLC , an established CRO providing clinical ... pharmaceutical and biotechnology industry, announced today that Manager of ... Outsourcing in Clinical Trials New England conference , September ... in Boston, MA.   (Logo: http://photos.prnewswire.com/prnh/20110719/SF36975LOGO ...
Cached Medicine Technology:Qualitest Pharmaceuticals Issues a Nationwide Voluntary Recall of Oral Contraceptives 2ClinStar to Present on Russia's Performance as an Emerging Market in Global Clinical Trials 2
ReNu 1 Step Enzymatic Cleaner with ReNu Multi-Purpose Solution removes protein deposits while lenses are being disinfected. Its a one-step process that saves time. Removes stubborn deposits from dai...
...
Wet-Field Hemostatic Eraser bipolar tip, packsize is 10/box....
... intraocular lenses. The instrument consists of a ... implant and divides the implant into two ... halves of the lens so that unwanted ... chamber is avoided. The instrument is passed ...
Medicine Products: